GTS Securities’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
132,820
+52,344
| +65% | +$4.34M | 0.49% | 31 |
|
|
2025
Q1 | $6.53M | Buy |
80,476
+11,544
| +17% | +$936K | 0.28% | 43 |
|
|
2024
Q4 | $6.21M | Sell |
68,932
-27,713
| -29% | -$2.5M | 0.3% | 48 |
|
|
2024
Q3 | $9.55M | Buy |
96,645
+78,977
| +447% | +$7.8M | 0.02% | 87 |
|
|
2024
Q2 | $1.64M | Buy |
17,668
+878
| +5% | +$81.4K | ﹤0.01% | 467 |
|
|
2024
Q1 | $1.59M | Buy |
16,790
+13,652
| +435% | +$1.3M | ﹤0.01% | 404 |
|
|
2023
Q4 | $280K | Sell |
3,138
-77,576
| -96% | -$6.93M | ﹤0.01% | 1169 |
|
|
2023
Q3 | $5.89M | Buy |
+80,714
| New | +$5.89M | 0.01% | 140 |
|